Menopausal Symptoms and Management — MCQs

10 questions

A 46-year-old woman presents for her annual examination. Her main complaint is frequent sweating episodes with a sensation of intense heat starting at her upper chest and spreading up to her head. These have been intermittent for the past 6 to 9 months but are gradually worsening. She has three to four flushing/sweating episodes during the day and two to three at night. She occasionally feels her heart race for about a second, but when she checks her pulse it is normal. She reports feeling more tired and has difficulty with sleep due to sweating. She denies major life stressors. She also denies weight loss, weight gain, or change in bowel habit. Her last menstrual cycle was 3 months ago. Physical examination is normal. Which treatment is most appropriate in alleviating this woman's symptoms?

Hormone Replacement Therapy (HRT) in postmenopausal women is beneficial in all these except

Menopausal hot flushes occur due to

In menopause, which of the following is seen:

For a menopausal patient having hot flashes, which of the following can be given as treatment?

Which of the following is an indication for use of Hormone Replacement Therapy in menopausal women:-

What is the primary hormonal cause of hot flushes experienced during menopause?

All of the following are true about hot flushes EXCEPT:

Which of the following is NOT effective in controlling the hot flushes of menopause in a woman?

Q10

Hormone Replacement therapy is not indicated in:

Menopausal Symptoms and Management Indian Medical PG Practice Questions and MCQs

Question 1: A 46-year-old woman presents for her annual examination. Her main complaint is frequent sweating episodes with a sensation of intense heat starting at her upper chest and spreading up to her head. These have been intermittent for the past 6 to 9 months but are gradually worsening. She has three to four flushing/sweating episodes during the day and two to three at night. She occasionally feels her heart race for about a second, but when she checks her pulse it is normal. She reports feeling more tired and has difficulty with sleep due to sweating. She denies major life stressors. She also denies weight loss, weight gain, or change in bowel habit. Her last menstrual cycle was 3 months ago. Physical examination is normal. Which treatment is most appropriate in alleviating this woman's symptoms?

A. Estrogen plus progesterone (Correct Answer)
B. Citalopram
C. Estrogen
D. Levothyroxine

Explanation: ***Estrogen plus progesterone*** - This patient's symptoms (hot flashes, night sweats, fatigue, sleep disturbance, irregular menses) are highly suggestive of **perimenopause/menopause**. **Hormone replacement therapy (HRT)** with estrogen and progesterone is the most effective treatment for managing severe menopausal symptoms. - Adding **progesterone** is crucial for women with an intact uterus to prevent **endometrial hyperplasia** and **endometrial cancer** caused by unopposed estrogen therapy. *Citalopram* - **Selective serotonin reuptake inhibitors (SSRIs)** like citalopram can reduce the frequency and severity of hot flashes, but they are generally reserved for women who cannot take or prefer not to take HRT due to contraindications or concerns. - SSRIs are less effective than HRT for severe vasomotor symptoms and do not address other menopausal symptoms like vaginal dryness or bone loss. *Estrogen* - While estrogen is the primary hormone for alleviating menopausal symptoms, administering **unopposed estrogen** to a woman with an intact uterus significantly increases the risk of **endometrial hyperplasia** and **endometrial carcinoma**. - Progesterone is necessary to counteract the proliferative effects of estrogen on the endometrium, preventing these risks. *Levothyroxine* - **Levothyroxine** is used to treat **hypothyroidism**, a condition that can cause fatigue, weight changes, and menstrual irregularities. - However, the patient's primary symptoms of prominent hot flashes and night sweats are not characteristic of hypothyroidism, and her physical examination is normal, making this diagnosis less likely.

Question 2: Hormone Replacement Therapy (HRT) in postmenopausal women is beneficial in all these except

A. Vaginal atrophy
B. Osteoporosis
C. Vasomotor symptoms
D. Prevention of CAD (Correct Answer)

Explanation: ***Prevention of CAD*** - While HRT was initially thought to be cardioprotective, large-scale studies like the **Women's Health Initiative (WHI)** demonstrated that it does **not prevent coronary artery disease (CAD)** and may even increase the risk of cardiovascular events, especially in older postmenopausal women or those initiating therapy years after menopause. - The potential benefits regarding CAD prevention are outweighed by risks such as **stroke** and **venous thromboembolism**. *Vaginal atrophy* - **Estrogen deficiency** in postmenopausal women leads to thinning, dryness, and inflammation of the vaginal walls, causing symptoms like dryness, irritation, and painful intercourse. - **Local or systemic estrogen therapy** effectively reverses these changes by restoring vaginal tissue health. *Osteoporosis* - **Bone loss** accelerates after menopause due to declining estrogen levels, increasing the risk of osteoporosis and fractures. - HRT, particularly estrogen, is effective in **preventing and treating osteoporosis** by inhibiting bone resorption and preserving bone mineral density. *Vasomotor symptoms* - **Hot flashes** and **night sweats** are common and often debilitating symptoms of menopause, directly linked to fluctuating and declining estrogen levels. - HRT, especially systemic estrogen, is the **most effective treatment** for alleviating these symptoms by stabilizing thermoregulatory control.

Question 3: Menopausal hot flushes occur due to

A. Decrease in estrogen (Correct Answer)
B. FSH secretion
C. Increase in progesterone
D. Increase in estrogen

Explanation: ***Decrease in estrogen*** - **Decreased estrogen** levels in menopause lead to a narrowing of the **thermo-neutral zone**, causing the body to be more sensitive to small changes in core body temperature. - This hormonal withdrawal results in **vasodilation** and a sensation of heat, culminating in a hot flush. *FSH secretion* - While **FSH (Follicle-Stimulating Hormone)** levels do increase significantly during menopause due to reduced negative feedback from estrogen, FSH itself does not directly cause hot flushes. - The elevated FSH is a consequence of ovarian failure and is a marker of menopause, but the primary cause of hot flashes is the estrogen withdrawal. *Increase in progesterone* - **Progesterone levels actually decline** during menopause as ovulation ceases. - An increase in progesterone is not associated with hot flushes; rather, cyclical progesterone therapy can sometimes mitigate symptoms in certain hormonal contexts. *Increase in estrogen* - Hot flushes are a hallmark symptom of **estrogen deficiency**, not an increase in estrogen. - Conditions involving increased estrogen (e.g., pregnancy or certain tumors) would not typically present with menopausal hot flushes.

Question 4: In menopause, which of the following is seen:

A. High FSH (Correct Answer)
B. High progesterone
C. High estrogen
D. Low FSH

Explanation: ***High FSH*** - In **menopause**, the ovaries lose their ability to produce **estrogen** and **progesterone**, leading to a decline in their levels. - This decline in ovarian hormones removes the **negative feedback** on the **hypothalamus** and **anterior pituitary**, causing a compensatory increase in **gonadotropin-releasing hormone (GnRH)**, **follicle-stimulating hormone (FSH)**, and **luteinizing hormone (LH)**. *High progesterone* - **Progesterone** levels are typically **low** in menopause because the ovaries are no longer ovulating or producing the corpus luteum, which is the primary source of progesterone. - While progesterone is important in the normal menstrual cycle, its production ceases after the final menstrual period. *High estrogen* - **Estrogen** levels are generally **low** in menopause due to the cessation of ovarian follicular activity. - The decline in estrogen is responsible for many menopausal symptoms, such as hot flashes and vaginal dryness. *Low FSH* - **Low FSH** is typically seen in conditions where there is sufficient **estrogen** and **progesterone** exerting negative feedback on the pituitary, or in primary pituitary/hypothalamic dysfunction. - In menopause, the **lack of ovarian hormones** specifically causes FSH (and LH) levels to be significantly elevated.

Question 5: For a menopausal patient having hot flashes, which of the following can be given as treatment?

A. Progesterone
B. 17β-estradiol (Correct Answer)
C. Danazol
D. Gonadotropin

Explanation: ***17β-estradiol*** - **Estrogen therapy** is the **gold standard** and **most effective treatment** for menopausal vasomotor symptoms including hot flashes - **17β-estradiol** directly replaces the declining ovarian estrogen levels that cause hot flashes - Recommended by all major guidelines (NAMS, ACOG, IMS) as **first-line therapy** for moderate to severe vasomotor symptoms - Available in various formulations: oral, transdermal patches, gels, and sprays - In women with an intact uterus, progestogen must be added to prevent endometrial hyperplasia *Progesterone* - **Progestogens** (synthetic progesterone) are primarily used to **protect the endometrium** when estrogen is prescribed to women with an intact uterus - Can provide **mild relief** of hot flashes in some women, but are **significantly less effective** than estrogen therapy - May be considered as **monotherapy** only when estrogen is contraindicated (e.g., breast cancer, thromboembolic disease) - **Not first-line treatment** for vasomotor symptoms *Danazol* - An **attenuated androgen** with anti-estrogenic and androgenic properties - Used primarily for **endometriosis** and **fibrocystic breast disease** - Would **worsen menopausal symptoms** including hot flashes due to its anti-estrogenic effects - Contraindicated in menopause management *Gonadotropin* - **FSH and LH** levels are already **markedly elevated** in menopause due to lack of negative feedback from ovarian hormones - Used in **fertility treatment**, not menopausal symptom management - Exogenous gonadotropin administration is **inappropriate and ineffective** for hot flashes

Question 6: Which of the following is an indication for use of Hormone Replacement Therapy in menopausal women:-

A. Post menopausal bleeding
B. Hot flushes (Correct Answer)
C. Cardiovascular protection
D. Pyelonephritis

Explanation: ***Hot flushes*** - Hormone Replacement Therapy (HRT) is highly effective in alleviating **vasomotor symptoms** like hot flushes and night sweats, which can severely impact quality of life in menopausal women. - The primary goal of using HRT is to manage these **menopausal symptoms** when they are bothersome. *Post menopausal bleeding* - **Postmenopausal bleeding** is a contraindication, not an indication, for new HRT initiation as it requires investigation to rule out endometrial pathology, including cancer. - If a woman on HRT experiences bleeding, it warrants immediate investigation to determine its cause and may necessitate stopping or changing the HRT regimen. *Cardiovascular protection* - While earlier beliefs suggested HRT offered cardiovascular protection, current evidence, particularly from the **Women's Health Initiative (WHI) study**, showed that HRT does not provide primary or secondary cardiovascular protection. - In fact, HRT may increase the risk of **cardiovascular events** like stroke and venous thromboembolism, especially when initiated many years after menopause. *Pyelonephritis* - **Pyelonephritis** is an infection of the kidney, typically caused by bacteria, and is not directly related to menopausal symptoms or hormonal status. - Treatment for pyelonephritis involves **antibiotics** and supportive care, not HRT.

Question 7: What is the primary hormonal cause of hot flushes experienced during menopause?

A. Increased noradrenaline with normal estrogen levels
B. Increased noradrenaline
C. Decreased estrogen levels (Correct Answer)
D. Both increased noradrenaline and decreased estrogen levels

Explanation: ***Decreased estrogen levels*** - **Decreased estrogen** is the primary hormonal change during menopause, leading to thermoregulatory dysfunction in the hypothalamus. - This hormonal imbalance causes the **vasomotor symptoms** like hot flushes and night sweats. *Increased noradrenaline* - While **noradrenaline** (norepinephrine) is involved in thermoregulation, its increase is a **secondary event** triggered by the initial estrogen deficiency, not the primary cause. - Increased noradrenaline can exacerbate the **vasodilation** and heat dissipation experienced during a hot flush. *Increased noradrenaline with normal estrogen levels* - This option is incorrect because hot flushes are characteristic of menopause, which is defined by **decreased estrogen levels**. - **Normal estrogen levels** would typically prevent the severe thermoregulatory instability that causes hot flushes. *Both increased noradrenaline and decreased estrogen levels* - Although both factors are involved, the question asks for the **primary hormonal cause**. **Decreased estrogen** initiates the cascade of events, including the subsequent alteration of neurotransmitter levels like noradrenaline. - Noradrenaline's role is more of a **mediator** in the physiological response to the primary estrogen deficiency.

Question 8: All of the following are true about hot flushes EXCEPT:

A. Possible role of serotonin is implicated
B. Can start several years before menopause
C. Can persist for several years after menopause
D. Can affect the entire body, not just specific regions (Correct Answer)

Explanation: ***Can affect the entire body, not just specific regions*** - While hot flashes are experienced as a **systemic sensation of heat**, they are predominantly characterized by intense warmth in the **upper body**, head, and neck, along with sweating, flushing, and palpitations. - The sensation of warmth is usually perceived to emanate from the chest or neck, spreading upwards, rather than encompassing the entire body uniformly. *Possible role of serotonin is implicated* - The **pathophysiology of hot flashes** is complex and involves neurotransmitter systems, with **serotonin** (5-HT) pathways in the brain playing a significant role in thermoregulation. - Drugs that modulate serotonin, such as **selective serotonin reuptake inhibitors (SSRIs)**, have been shown to reduce the frequency and severity of hot flashes. *Can start several years before menopause* - **Vasomotor symptoms**, including hot flashes, often begin during the **perimenopause**, which is the transitional period leading up to menopause. - This phase typically starts several years before the final menstrual period, when **hormonal fluctuations**, particularly in estrogen levels, become more pronounced. *Can persist for several years after menopause* - For many women, hot flashes can continue for an extended period into the **postmenopausal years**. - Studies indicate that the duration of hot flashes can vary widely, with some women experiencing them for **more than 10 years** after their final menstrual period.

Question 9: Which of the following is NOT effective in controlling the hot flushes of menopause in a woman?

A. Raloxifene (Correct Answer)
B. Isoflavones
C. Hormone replacement therapy
D. Tibolone

Explanation: ***Raloxifene*** - **Raloxifene** is a selective estrogen receptor modulator (SERM) that acts as an estrogen agonist in bone tissue, helping to prevent osteoporosis, but it is an estrogen antagonist in other tissues and can actually worsen or induce **hot flushes**. - Its primary indications are for the prevention and treatment of **osteoporosis** in postmenopausal women, and for the reduction of risk of invasive breast cancer in high-risk women. *Isoflavones* - **Isoflavones** (e.g., from soy) are phytoestrogens that can have weak estrogenic effects, and some women find them helpful in reducing the frequency and severity of **hot flushes**, though efficacy varies. - They bind to estrogen receptors, potentially mitigating the sudden drops in estrogen that lead to **vasomotor symptoms**. *Hormone replacement therapy* - **Hormone replacement therapy (HRT)**, which involves estrogen with or without progestin, is the most effective treatment for **menopausal hot flushes**. - By replacing declining estrogen levels, HRT directly addresses the underlying cause of **vasomotor instability**. *Tibolone* - **Tibolone** is a synthetic steroid that has estrogenic, progestogenic, and androgenic properties, and it is effective in relieving **menopausal hot flushes**. - It specifically targets estrogen receptors in the hypothalamus, which helps to stabilize **thermoregulatory control** and reduce hot flushes.

Question 10: Hormone Replacement therapy is not indicated in:

A. Vaginal atrophy
B. Osteoporosis
C. Prevention of CAD (Correct Answer)
D. Hot flashes

Explanation: ***Prevention of CAD*** - Hormone replacement therapy (HRT) is **not indicated** for the primary or secondary prevention of **Coronary Artery Disease (CAD)**. While observational studies initially suggested a benefit, large randomized controlled trials (e.g., WHI) showed no cardiovascular protection and even an increased risk of stroke and venous thromboembolism. - The benefits of HRT for menopausal symptoms generally outweigh the risks only in select women, and CAD prevention is not one of them. *Vaginal atrophy* - **Vaginal atrophy**, characterized by dryness, irritation, and painful intercourse, is a common menopausal symptom effectively treated with **local estrogen therapy**. - Systemic HRT can also alleviate these symptoms, but local therapy is often preferred for isolated vaginal symptoms to minimize systemic exposure. *Osteoporosis* - HRT, particularly estrogen therapy, is an effective treatment for the **prevention and management of postmenopausal osteoporosis**, preventing bone loss and reducing the risk of fractures. - However, it is generally considered a second-line option for osteoporosis, after non-hormonal therapies, due to potential risks. *Hot flashes* - **Hot flashes** (vasomotor symptoms) are one of the most common and bothersome symptoms of menopause, and **systemic HRT** is the **most effective treatment** available. - Estrogen therapy significantly reduces the frequency and severity of hot flashes, improving quality of life for many women.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free